Stopping 'superbugs' in their tracks

Scientists and researchers must quickly develop new strategies to prevent the spread of antibiotic resistant 'superbugs.'

December 3, 2011 08:37
3 minute read.
a hospital in Jerusalem

hospital 311. (photo credit: Marc Israel Sellem)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

University of Virginia Health System researchers are the first in the world to develop a new and faster method to track major infection-causing “superbugs” – a major key in preventing the spread of deadly infections.

Their research, published in the November/December 2011 issue of the online journal mBio, comes at a critical time.

Be the first to know - Join our Facebook page.

Several newly discovered genes such as KPC (Klebsiella pneumoniae carbapenemase) and NDM (New Delhi metallo-betalactamase) have experts on alert for several reasons: their ability to easily transform bacteria into antibiotic-resistant superbugs, their unprecedented ability to cross over into different strains and species of bacteria, the ease with which they can transfer to highly infectious bacteria, such as Salmonella and cholera and the potential for these genes to easily establish themselves undetected in our environment.

“When you’re in a race against time to halt the spread of these life-threatening infections, the traditional methods of detection and tracking are very difficult and frankly take too long,” says UVA Medical Center Epidemiologist Costi Sifri, MD, study principal investigator.

Decoding deadly hospital-acquired infections

The focus of their study was KPC, a gene Sifri calls “perhaps the most important new resistance gene of the millennium.” KPC has the ability to easily hitch a ride on movable genetic elements called plasmids that then spread between pathogens, making them highly infectious and deadly.

Through their new method, Sifri’s research team was able to quickly track the movement of plasmids carrying KPC between bacteria and understand the spread of KPC bacteria at the molecular level.

While traditional methods take several weeks or months to do this analysis and can only be performed in specialized research laboratories, the method developed by the UVA team takes only one to two days and can be performed by most modern microbiology laboratories.

“We developed and successfully used a novel technique to rapidly track the gene’s movement between patients and bacteria,” says lead author Dr. Amy Mathers, assistant professor in the UVA School of Medicine’s Division of Infectious Diseases and International Health.

“We were able to show that all cases in a cluster of hospital infections could be traced back to a single patient. Most cases were linked by movement of the KPC gene between different bacteria.”

Armed with this information, the research team hopes to develop new strategies and tools to prevent the spread of these highly resistant bacteria to other patients.

The pathogens associated with this new gene are called CRE, or Carbapenem- Resistant Enterobacteriaceae, and include E. coli and Klebsiella, among others. Infections caused by CRE are associated with very high mortality rates, Sifri says.

A global health threat

“These pathogens are widely considered a major healthcare threat in the United States and worldwide,” says Sifri. “Monitoring their origin and spread is critical to preventing serious outbreaks in hospitals, other healthcare facilities, and potentially the general population.”

In fact, another drug resistant gene called NDM emerged last year as a cause of significant disease in India and may be acquired through drinking water. The pathogen spread quickly and was carried to the U.S. and Great Britain.

“Carbapenems have become essential antibiotics for the treatment of many infections in hospitals today, and their potential loss as a reliably effective class of antibiotics is a serious public health threat," Sifri says. "The more rapidly we can detect CRE and understand movement of KPC gene in hospitalized patients, the more quickly we can intervene to prevent CRE spread to other patients and bacteria. This is fundamentally important for maintaining the effectiveness of this important class of antibiotics.”

The study “Molecular Dissection of an Outbreak of Carbapenem-Resistant Enterobacteriaceae Reveals Intergenus KPC Carbapenemase Transmission through a Promiscuous Plasmid,” can be found online in the mBio November/December 2001 issue.

This article was first published at

Related Content

August 31, 2014
Weizmann scientists bring nature back to artificially selected lab mice